Frontier Biotechnologies Inc (688221)

Currency in CNY
20.56
+0.70(+3.53%)
Delayed Data·
688221 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
19.6721.01
52 wk Range
13.0629.98
Key Statistics
Bid/Ask
20.55 / 20.57
Prev. Close
19.86
Open
19.86
Day's Range
19.67-21.01
52 wk Range
13.06-29.98
Volume
10.91M
Average Volume (3m)
21.39M
1-Year Change
4.9155%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
688221 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 0.00

Earnings

Latest Release
Apr 25, 2026
EPS / Forecast
0.61 / --
Revenue / Forecast
297M / --
EPS Revisions
Last 90 days

688221 Income Statement

Compare 688221 to Peers and Sector

Metrics to compare
688221
Peers
Sector
Relationship
P/E Ratio
2,148.6x−2.0x−0.4x
PEG Ratio
21.100.150.00
Price/Book
6.7x4.9x2.6x
Price / LTM Sales
19.0x18.6x2.9x
Upside (Analyst Target)
-52.7%58.0%
Fair Value Upside
Unlock−1.5%9.5%Unlock

Frontier Biotechnologies Inc., a commercial-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes various medicines that improve patients’ health in China. It offers Aikening, an IV fusion inhibitor for dual therapy of HIV-1. The company’s pipeline products include FB2004 indicated for HBV; FB7011 and FB7013 for IgA nephropathy; FB7012 to treat hyperuricemia and gout; FB7041 to treat tumors; FB7024 for the treatment of hyperlipidemia; FB7023 to treat ASCVD; FB7033 for the treatment of MASH; FB4001 for osteoporosis; and FB3002 for pain management. Frontier Biotechnologies Inc. was founded in 2002 and is headquartered in Nanjing, China.

Employees
314
Market
China

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
46.95M12.53%932.44M
Other Institutional Investors
125.20M33.43%2.49B
Public Companies & Retail Investors
202.42M54.04%4.02B
Total
374.58M100.00%7.44B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Baobab Pharmaceuticals Limited18.86%70,638,7501,402,886
Nanjing Jianmu Enterprise Consulting Partnership Enterprise (Limited Partnership)4.59%17,200,000341,592

FAQ

What Is the Frontier Biotechnologies (688221) Stock Price Today?

The Frontier Biotechnologies stock price today is 20.56 CNY.

What Stock Exchange Does Frontier Biotechnologies Trade On?

Frontier Biotechnologies is listed and trades on the Shanghai Stock Exchange.

What Is the Stock Symbol for Frontier Biotechnologies?

The stock symbol for Frontier Biotechnologies is "688221."

What Is the Frontier Biotechnologies Market Cap?

As of today, Frontier Biotechnologies market cap is 7.44B CNY.

What Is Frontier Biotechnologies's Earnings Per Share (TTM)?

The Frontier Biotechnologies EPS (TTM) is 0.01.

When Is the Next Frontier Biotechnologies Earnings Date?

Frontier Biotechnologies will release its next earnings report on Aug 31, 2026.

From a Technical Analysis Perspective, Is 688221 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Frontier Biotechnologies Stock Split?

Frontier Biotechnologies has split 0 times.

How Many Employees Does Frontier Biotechnologies Have?

Frontier Biotechnologies has 314 employees.

What is the current trading status of Frontier Biotechnologies (688221)?

As of Jul 27, 2026, Frontier Biotechnologies (688221) is trading at a price of 20.56 CNY, with a previous close of 19.86 CNY. The stock has fluctuated within a day range of 19.67 CNY to 21.01 CNY, while its 52-week range spans from 13.06 CNY to 29.98 CNY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.